The Functional Neuroanatomy of Catastrophizing: an fMRI Study
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This is a brain imaging study of pain responses. The study includes 2-7 visits, lasting from 1-2 hours each. You may be eligible if you are over 18 years old, are either generally healthy or have fibromyalgia, do not have a serious heart condition or certain other medical conditions, are not taking certain types of medications, and are not pregnant.The research takes place at the Brigham & Women's Pain Management Center, 850 Boylston St, Chestnut Hill, and at the MGH Martinos Center for Biomedical Imaging. For further information, please contact the study coordinator Chrissie Cahalan at 617-732-9014 or by email at CCahalan1@partners.org.
| Condition | Intervention |
|---|---|
|
Fibromyalgia |
Behavioral: Cognitive Behavioral Therapy Behavioral: Education |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment |
| Official Title: | The Functional Neuroanatomy of Catastrophizing: an fMRI Study |
- Use fMRI to assess the impact of catastrophizing on central pain processing [ Time Frame: 6 weeks ] [ Designated as safety issue: No ]Catastrophizing is a critically-important variable in shaping pain experiences. However, as only a single functional neuroimaging study of catastrophizing has been published (Gracely et al., 2004), we know little about the CNS correlates of pain-related catastrophizing. We will use fMRI to study individuals with arthritis, divided into high- and low-catastrophizers, during the experience of acute thermal pain.
| Enrollment: | 70 |
| Study Start Date: | August 2010 |
| Study Completion Date: | December 2011 |
| Primary Completion Date: | November 2011 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Cognitive-Behavioral Therapy
Practicing certain strategies such as relaxation and changing negative thoughts about pain.
|
Behavioral: Cognitive Behavioral Therapy
Practicing certain strategies such as relaxation and changing negative thoughts about pain.
|
|
Placebo Comparator: Education
Giving information about pain and how to change perceptions of pain.
|
Behavioral: Education
Giving you information about pain and how to change perceptions of pain.
|
Detailed Description:
This research is being done to learn about brain activation during brief applications of painful stimuli using MRI, a technique for making images pictures of the brain. MRI uses magnetic fields and radio waves and is not harmful. This study uses a new investigational technique called functional MRI (fMRI) which is a very fast MRI technique that will allow the investigators to evaluate changes in how blood flows to parts of your brain during the experience of pain. Findings from this study will have implications for understanding individual differences in the experience of pain.
If you are over 18 and have Fibromyalgia or are generally healthy, you may be eligible. Other eligibility criteria include: no major circulation or heart problems, nerve damage, and no use of certain kinds of medications or other substances. This study involves a first visit to the Brigham & Women's Pain Management Center, and a second visit to the MRI facility at MGH.
The first visit will be a screening visit, lasting around 2 hours. The second visit will involve a session of fMRI assessment and will last around 2 hours. Both of these visits will involve 2 kinds of tests to measure your sensory responses to pressure. For all of these tests, you can stop at any time.
Depending on your responses to pain, you may be invited to participate in a follow-up treatment study. This involves 4 visits with Dr. Edwards, the clinical psychologist and principle investigator of this study, for therapy that addresses thoughts about pain or Fibromyalgia education. These sessions will be followed by another fMRI visit identical to visit 2. You do not have to participate in this study, and if you start the study you can leave at any time without affecting your future treatment or participation in research studies.
If you would like to learn more about the study, please contact the study coordinator Chrissie Cahalan (617-732-9014 or ccahalan1@partners.org).
Eligibility| Ages Eligible for Study: | 18 Years to 70 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Age 18 or older
- Meet ACR criteria for RA or FM or be free from chronic pain and rheumatic disease
- Score on the Pain Catastrophizing Scale in either the top or bottom third of the normative distribution
Exclusion Criteria:
- History of anxiety disorders or significant anxiety symptoms interfering with fMRI procedures (e.g., panic)
- History of cardiac events
- History of significant head injury
- Peripheral neuropathy
- Use of certain centrally-acting analgesic medications other than over-the-counter preparations (which will be withdrawn for 24 hours prior to testing) or use of recreational drugs
- Implanted medical or metallic objects
- Pregnancy
- Cardiac or nervous system disease
Contacts and Locations| United States, Massachusetts | |
| Brigham and Women's Hospital | |
| Chestnut Hill, Massachusetts, United States, 02467 | |
| Principal Investigator: | Robert R Edwards, PhD | Brigham and Women's Hospital |
More Information
No publications provided
| Responsible Party: | Robert Edwards, Robert R. Edwards PhD, Brigham and Women's Hospital |
| ClinicalTrials.gov Identifier: | NCT01345344 History of Changes |
| Other Study ID Numbers: | 2009p001021 |
| Study First Received: | April 27, 2011 |
| Last Updated: | February 21, 2013 |
| Health Authority: | United States: Institutional Review Board |
Additional relevant MeSH terms:
|
Fibromyalgia Myofascial Pain Syndromes Muscular Diseases Musculoskeletal Diseases |
Rheumatic Diseases Neuromuscular Diseases Nervous System Diseases |
ClinicalTrials.gov processed this record on June 18, 2013